Financing, Equity Capital Markets

Pliant Therapeutics, Inc.

01/23
|
$287.5 Million
Piper Sandler served as bookrunner for Pliant Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma